|
|
||||||||
TRANSLATIONAL PHYSIOLOGY
School of Pharmacy, University of Wisconsin, Madison, Wisconsin 53705
Submitted 10 December 2002 ; accepted in final form 26 February 2003
It is clear that ischemia inhibits successful defibrillation by altering
regional electro-physiology. However, the exact mechanisms are unclear. This
study investigated whether regional gap junction inhibition increases biphasic
shock defibrillation thresholds (DFT). Sixteen swine were instrumented with a
mid-left anterior descending (LAD) perfusion catheter for regional infusion of
0.5 mM/h heptanol (n = 8) or saline (n = 8). DFT values and
effective refractory periods (ERP) at five myocardial sites were determined.
Regional conduction velocity (CV) was determined in an LAD drug-perfused and
nondrug-perfused region in an additional seven swine. Regional heptanol
infusion increased 50% DFT values by 33% (P = 0.01) and slowed CV by
4259% (P < 0.01) but did not affect ERP. Regional heptanol
also increased CV dispersion by
270% (P < 0.05) but did not
change ERP dispersion. Regional placebo did not alter any of these parameters.
Furthermore, regional heptanol infusion induced spontaneous ventricular
fibrillation in eight of eight animals. Increasing spatial conduction velocity
dispersion by impairing regional gap junction conductance increased DFT
values. Dispersion in conduction velocity slowing during regional ischemia may
be an important determinant of defibrillation efficacy.
conduction velocity; electric countershock; ventricular arrhythmias
This article has been cited by other articles:
![]() |
J.-q. Zhong, G. Laurent, P. P.-S. So, Xudong Hu, J. K. Hennan, and P. Dorian Effects of Rotigaptide, a Gap Junction Modifier, on Defibrillation Energy and Resuscitation From Cardiac Arrest in Rabbits Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2007; 12(1): 69 - 77. [Abstract] [PDF] |
||||
![]() |
B. C. Eloff, E. Gilat, X. Wan, and D. S. Rosenbaum Pharmacological Modulation of Cardiac Gap Junctions to Enhance Cardiac Conduction: Evidence Supporting a Novel Target for Antiarrhythmic Therapy Circulation, December 23, 2003; 108(25): 3157 - 3163. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |